181 related articles for article (PubMed ID: 7171894)
21. Treatment. Corticosteroids and anti-inflammatory drugs.
Kimberly RP
Rheum Dis Clin North Am; 1988 Apr; 14(1):203-21. PubMed ID: 3041489
[TBL] [Abstract][Full Text] [Related]
22. The application of plasmapheresis in systemic lupus erythematosus.
Jones JV
Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
[No Abstract] [Full Text] [Related]
23. [Fundamentals and problems of lupus erythematosus therapy].
Randow U; Sönnichsen N; Weidauer S
Z Gesamte Inn Med; 1968 Sep; 23(17):513-9. PubMed ID: 4882481
[No Abstract] [Full Text] [Related]
24. The efficacy of antimalarials in systemic lupus erythematosus.
Nayak V; Esdaile JM
Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906
[TBL] [Abstract][Full Text] [Related]
25. [Development and long term prognosis of lupus erythematosus (apropos of 124 cases)].
Godeau P; Betourne C; Piette JC; Herreman G; Wechsler B; Levy R
Ann Med Interne (Paris); 1977 Jan; 128(1):17-30. PubMed ID: 855968
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of severe systemic lupus erythematosus].
Schmidt RE; Witte T; Deicher H; Neumann KH; Schaumann D; Koch KM
Dtsch Med Wochenschr; 1991 Dec; 116(49):1891-3. PubMed ID: 1743102
[No Abstract] [Full Text] [Related]
27. Lupus and the heart-joint connection.
Johns Hopkins Med Lett Health After 50; 2002 Apr; 14(2):4-5. PubMed ID: 11951823
[No Abstract] [Full Text] [Related]
28. The efficacy of antimalarials in systemic lupus erythematosus.
Esdaile JM
Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
[TBL] [Abstract][Full Text] [Related]
29. The management of collagen diseases.
Calin A
Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531
[No Abstract] [Full Text] [Related]
30. [Skin blood vessels in various types of lupus erythematosus during treatment].
Beljaewa HF; Smelow NS; Sjitsch LI; Trofimowa LJ
Dermatol Wochenschr; 1968 Jul; 154(27):631-6. PubMed ID: 5713471
[No Abstract] [Full Text] [Related]
31. Short and longterm experience with plasmapheresis in connective tissue diseases.
Dequeker J; Geusens P; Wielands L
Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
[TBL] [Abstract][Full Text] [Related]
32. [Aggressive therapy of highly active systemic lupus erythematosus].
Graninger W
Acta Med Austriaca; 1996; 23(4):129-33. PubMed ID: 9036724
[TBL] [Abstract][Full Text] [Related]
33. [New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
González T; Rodríguez-Lozano B; Hernández-Beriaín JA
Med Clin (Barc); 1991 Oct; 97(11):424-30. PubMed ID: 1961050
[No Abstract] [Full Text] [Related]
34. Systemic lupus erythematosus.
Madhok R; Wu O
Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
[No Abstract] [Full Text] [Related]
35. [Treatment of systemic lupus erythematosus systemic].
Piette JC
Rev Prat; 1998 Mar; 48(6):643-7. PubMed ID: 9781136
[TBL] [Abstract][Full Text] [Related]
36. [Comparative evaluation of the effectiveness of diverse variants of drug therapy in chronic glomerulonephritis].
Popova LA
Ter Arkh; 1979; 51(1):77-83. PubMed ID: 432837
[No Abstract] [Full Text] [Related]
37. Medical management of patients with disability due to arthritis.
Kantor TG
Arch Phys Med Rehabil; 1967 Mar; 48(3):142-4. PubMed ID: 6021491
[No Abstract] [Full Text] [Related]
38. Lupus therapy.
Baart de la Faille H
Clin Investig; 1994 Oct; 72(10):749-53. PubMed ID: 7865977
[No Abstract] [Full Text] [Related]
39. [Lupus erythematosus. 5. Current status and trends in therapy of lupus erythematosus: a) S.L.E.: therapy with antimalarials, steroid therapy and monitoring, acupuncture; b) D.L.E.; c) Therapy of oral lesions and xerostomia; d) Dental treatment during L.E].
Frojo M; Palomba F; Rullo R
Arch Stomatol (Napoli); 1989 Nov; 30(5):1113-25. PubMed ID: 2641870
[No Abstract] [Full Text] [Related]
40. Systemic lupus erythematosus: demographics, prognosis, and outcome.
Klippel JH
J Rheumatol Suppl; 1997 May; 48():67-71. PubMed ID: 9150122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
